Market Tracker

08/26 5:16pm ET

Albany Molecular Research Inc (NASDAQ:AMRI)

14.60
Delayed Data
As of Aug 26
 +0.32 / +2.24%
Today’s Change
12.45
Today|||52-Week Range
21.69
-26.45%
Year-to-Date
No recent news for Albany Molecular Research Inc.

Today’s Trading

Previous close14.28
Today’s open14.30
Day’s range14.29 - 14.67
Volume280,871
Average volume (3 months)301,960
Market cap$625.9M
Dividend yield--
Data as of 4:00pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+30.00%
Earnings growth (this year)+11.81%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+45.48%
P/E ratioNM
Price/Sales1.64
Price/Book1.81

Competitors

 Today’s
change
Today’s
% change
AMRNAmarin Corporation P...+0.01+0.33%
ARWRArrowhead Pharmaceut...+0.07+1.02%
RGNXRegenxbio Inc-0.08-0.64%
BSTCBiospecifics Technol...+0.54+1.48%
Data as of 4:00pm ET, 08/26/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)$0.22
Annual revenue (last year)$402.4M
Annual profit (last year)-$2.3M
Net profit margin-0.57%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
William S. Marth
Chief Operating Officer
George Svokos
Corporate headquarters
Albany, New York

Forecasts